A Prospective, Observational, Quality Improvement Study to Optimize Care for Lung Cancer Patients Undergoing Video-Assisted Thoracoscopic Surgery (VATS)
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Lung Cancer
- Sponsor
- Dana-Farber Cancer Institute
- Enrollment
- 173
- Locations
- 6
- Primary Endpoint
- Readmissions rates within 30 days of the patient's surgery date
- Status
- Completed
- Last Updated
- 6 years ago
Overview
Brief Summary
This is a research study for participants who have been diagnosed with lung cancer and are receiving VATS (Video Assisted Thoracoscopic Surgery) lobectomy or segmentectomy. The overall objective of this study is to develop a database to collect data on participants who are undergoing VATS lobectomy or segmentectomy for lung cancer.
Detailed Description
This database will be used as for quality improvement purposes. Furthermore, the database will help in collecting data in an organized fashion, which will help the investigators learn more about the details of the workup performed prior to the surgery, during the surgery, peri-operative management and early follow-up. The investigators hope that this database will help to determine a common guideline to perform VATS lobectomy or segmentectomy. By creating a common guideline for future treatment of VATS patients, the investigators predict the efficiency of the process will increase significantly without decreasing, and perhaps even improving, the quality of the procedure.
Investigators
Scott J. Swanson, MD
Principal Investigator
Dana-Farber Cancer Institute
Eligibility Criteria
Inclusion Criteria
- •Male and female subjects
- •Age ≥ 18 years
- •Underwent a VATS lobectomy or segmentectomy procedure for lung cancer -- Note: patients with other malignancies are eligible if they have a primary cancer of the lung as defined above
Exclusion Criteria
- •Subjects undergoing thoracotomy lobectomy or segmentectomy for lung cancer
- •Subjects undergoing surgical procedures other than VATS lobectomy or segmentectomy for lung cancer
Outcomes
Primary Outcomes
Readmissions rates within 30 days of the patient's surgery date
Time Frame: 30 Days
Incidence of post-operative complications within 30 days of the patient's surgery date
Time Frame: 30 Days
Total inpatient cost
Time Frame: 30 Days
Secondary Outcomes
- Difference in readmission rates between the two cohorts(3 years)